The proposed project results from the collaboration of three complementary research bodies, the Musculoskeletal Diseases Research Laboratory “Th. Garofalidis ”of the Medical School of EKPA, the Institute of Chemical Biology of the National Research Foundation, the Panhellenic Skeletal Health Association“ PETALOUDA ”and two Greek companies of CLOUDPHARM and LIFELNB.

Panagiotis Zoumboulakis (Coordinator), Collaborating Researcher, Associate Professor University of West Attica
Panagiotis Georgiadis, Principal Investigator
Theodora Katsila, Commissioned Researcher
Maria Zervou, Principal Investigator
Vasiliki Pletsa, Principal Investigator

The Institute of Chemical Biology (ICB) of the National Research Foundation aims to develop a modern, interdisciplinary research approach in the fields of health, medicine and biotechnology. The main activities of ICB include: 1) Development of new bioactive compounds against selected therapeutic objectives and their preclinical control with the aim of their possible utilization in the prevention and treatment of diseases 2) Utilization of modern holistic approaches of chemical and biological analysis in research and diagnosis in the early stages. The main infrastructures of ICB: NMR 300 and 600 MHz Spectrometers, UHPLC-LTQ Orbitrap Velos Mass Spectrometers, HPLC-LCQ Fleet (Thermo Scientific), DNA Sequencing Device (pyrosequencer), Next Generation Sequencer (IonTorrent). NHRF and ICB have experience in submitting and managing a large number of competing European and Greek research projects either as a coordinator or as a participating body.

Efstathios Chronopoulos, Associate Professor (Scientific Officer)
George Trovas, Endocrinologist
Efi Karlafti
Kelly Lambropoulou

EEPMS from 1979 until today, with its continuous action in the field of Metabolic Bone Diseases and with special emphasis on osteoporosis, consolidated its presence in the medical scientific community, both in Greece, being a Reference Center of the Ministry of Health for its Diseases Musculoskeletal System as well as abroad. The large number of research studies – clinical, multicenter, experimental – and doctoral dissertations have highlighted the importance of Metabolic Bone Diseases in the quality of life and the improvement of human life expectancy. In parallel with its research work, the Laboratory engages in didactic work with the organization of the undergraduate Elective Course “Metabolic Bone Diseases”, of the same name lasting two years.
Postgraduate Program of the Medical School of EKPA, as well as educational courses, seminars (unique in Greece, such as the continuous for 30 years “Microsurgery Practice” lasting three months and the European certified “LAS Course”) and conferences, addressed to scientists and researchers with related subjects

Tatiana Drakopoulou

Butterfly, Skeletal Health Association is a non-profit association, the only one officially recognized by the International Osteoporosis Foundation (IOF). It is addressed to the public and its main goal is to inform about skeletal health, diet, exercise, psychology, prevention and treatment of diseases related to it. Until now, the Association has developed active action and work both within the borders of Attica and throughout Greece. It has a very important project to highlight in the field of prevention since over 24,000 free osteoporosis/scoliosis measurements have been performed throughout Greece. The Butterfly has won first place for its outstanding course, among 186 countries, at the World Congress held in Miami in the United States in December 2007 as well as the 1st prize among 212 countries for the creation of the best publicity campaign (Best Media Campaign). , Finland, 2013).

Minos Matsoukas, CSO
Costas Potamitis

Cloudpharm is active in the field of biotechnology. It is a knowledge-intensive company and the management team consists of young scientists with research experience in pharmaceutical chemistry and information technology. Utilizing a computing platform of natural ingredients and a host of specialized computational chemistry tools, it offers innovative product design services with an emphasis on nutritional supplements and functional foods. It is the ideal research and development partner for small and medium enterprises in the field of medicine, food and cosmetics

Nikolaos Bardakis Managing Director

LIFE NLB Ltd. ( is a new company that introduces, develops and sells unique and original medical devices, nutritional supplements and pharmaceuticals in partnerships with both European companies (Enzymatica, Eubage) and in Greece (Cosmofarm, Cloudpharm)